Anzeige
Mehr »
Login
Sonntag, 12.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
Die 1 Billionen Dollar Mine: Power Nickels Weg zur globalen Dominanz!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
506 Leser
Artikel bewerten:
(2)

Versapay Welcomes Stoneridge Software as a Premier Partner

Finanznachrichten News

New partnership elevates Stoneridge Software's ERP payment systems and AR automation for customers

MIAMI, FL / ACCESSWIRE / October 24, 2023 / Versapay, the leader in Collaborative Accounts Receivable (AR), announced today that Stoneridge Software, a Microsoft Dynamics ERP Solutions Partner for Business Applications and Cloud Solution Provider, has been named a Versapay Premier Partner.

"We are thrilled to have Stoneridge Software as a part of our VersaPartner program," said Nancy Sansom, Versapay's Chief Commercial Officer. "We've had a longstanding relationship with Stoneridge Software, and firmly believe that they have one of the industry's best ERP and CRM integration platforms. We look forward to our continued collaboration and providing solutions that elevate Stoneridge Software's customer experience."

Renowned for their ERP and CRM integrations, Stoneridge Software excels in offering seamless upgrade paths for Dynamics AX, Dynamics NAV, Dynamics GP and Dynamics CRM. Now, as a Premier Partner, Stoneridge Software will have access to Versapay's world-class products, resources, and support for partners to drive digital payment adoption, transform accounts receivable teams, and provide more value to their customers.

"Stoneridge and Versapay have partnered to empower clients for nearly ten years," said Rich Studer, Stoneridge Software's Director of Sales. "Versapay's solution gives our clients the ability to process credit card payments seamlessly in their Dynamics 365 environments, streamlining payment processing from multiple steps to a single, efficient process. We are excited to continue to work together as part of this new Partner Program."

Versapay's VersaPartner program is composed of three partnership tiers including Associate, Plus, and the highest tier, Premier. In addition, the partnership means that Stoneridge Software recommends Versapay as an approved solution provider for ERP payments and AR automation.

For more information on Versapay and the Versapartner program, visit Versapay.com.

About?Versapay

Versapay is a collaborative accounts receivable (AR) company. The Versapay Collaborative AR Network empowers the genius of teams by bridging the gap between suppliers and buyers through a shared, digital experience. Owned by Great Hill Partners, Versapay's employee base spans U.S. and Canada with offices in Toronto, Atlanta and Miami. With 9,000+ clients and 1 million+ buyers engaged, Versapay handles 40+ million new invoices and drives $60+ billion in global payment volume annually. Join the conversation at twitter.com/Versapay and linkedin.com/company/versapay. To learn more about Versapay and its collaborative AR solutions please visit: versapay.com.

About Stoneridge Software

Stoneridge Software is a Microsoft Inner Circle Partner representing the entire suite of Dynamics 365 solutions, Power Platform and Modern Workplace, with focused verticals in Agriculture, Manufacturing, Distribution and Professional Services. In addition to implementing and supporting Microsoft Dynamics, Stoneridge is your full-service partner offering Microsoft license management, cloud consulting for

Microsoft Azure, security, identity, and access as well as organizational change management and training.

Versapay Media Contact:

Sarah Weaver
Caliber Corporate Advisers
versapay@calibercorporateadvisers.com

SOURCE: Versapay

View source version on accesswire.com:
https://www.accesswire.com/795543/versapay-welcomes-stoneridge-software-as-a-premier-partner

© 2023 ACCESSWIRE
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.